Skip to main content

Advertisement

Table 2 Number of virus-positive patients and virus distribution between treatment groups*

From: Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial

  n VP patients* RSV Corona 229E Corona OC43 hMPV hRV Influenza A PIV3
ITT 118/203 4 32 21 5 60 13 1
V 59/102 3 16 13 2 27 7 0
P 59/101 1 16 8 3 33 6 1
  1. *Some patients had more than one virus.
  2. hMPV = Human metapneumovirus; hRV = Human rhinovirus; ITT = Intention to treat population; P = Placebo; PIV3 = Parainfluenza virus type 3; V = Carrageenan; VP = Virus-positive patients.